SAN DIEGO--(BUSINESS WIRE)--May 3, 2006--Illumina, Inc.(NASDAQ:ILMN) announced today that Christian Henry, Vice President andChief Financial Officer, will participate in an upcoming life sciencediscussion panel hosted by Leerink Swann & Co. in New York City. Theevent organizers have provided Mr. Henry and other roundtableparticipants the opportunity to present overviews of their respectivecompanies.
Mr. Henry's 30-minute presentation will be webcast live beginningon or about 10:45 a.m. Eastern Time (ET) on Tuesday, May 9, 2006. Thefollowing webcast URL provides access to the live presentation as wellas an audio file that will be archived for 90 days following theevent: http://www.wsw.com/webcast/leerink3/ilmn/.
Illumina (www.illumina.com) is developing next-generation toolsthat permit large-scale analysis of genetic variation and function.The Company's proprietary BeadArray(TM) technology -- now used inleading genome centers around the world -- provides the throughput,cost effectiveness and flexibility to enable researchers in the lifesciences and pharmaceutical industries to perform the billions oftests necessary to extract medically valuable information fromadvances in genomics and proteomics. This information will help pavethe way to personalized medicine by correlating genetic variation andgene function with particular disease states, enhancing drugdiscovery, allowing diseases to be detected earlier and morespecifically, and permitting better choices of drugs for individualpatients.
CONTACT: Illumina, Inc.
Jay Flatley, 858-202-4501
President & CEO
jflatley@illumina.com
or
William Craumer, 858-202-4667
Director, Corporate Communications
bcraumer@illumina.com
SOURCE: Illumina, Inc.